SS31 freeze-dried powder 99% Purity SS-31 to Treat Heart Elamipretide Lyophilized. Peptide
TDS 6 Inquiries
2805997-46-8
Pharmaceutical Grade
99%
HongKong
customizable
10 bottles per box
2026-09-07
GHK-CU,RETATRUTIDE
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Survodutide
Other Name:Survodutide;BI 456906;Survodutide Peptide;Survodutide(BI 456906) 10MG;Survodutide acetate;Suvorouti;Swertide peptide;Suvodutide
CAS No.:2805997-46-8
Molecular Weight:0
EC Number:997-146-8
Color/Form:White to off-white
Categories:
Research-
Class:
Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)
Status:FDA-approved (Forzinity) — Accelerated Approval 2025
Mechanism:A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.
Activity note:SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.
Source:Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI
Clinical Development:FDA:Forzinity (approved 2025-09-19)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
FDA: Forzinity (NDA 215244) — Accelerated Approval 2025; Genetics in Medicine: TAZPOWER Phase 2/3 results (Thompson et al. 2020); Drugs: Elamipretide First Approval (Springer 2025)
Disclaimer:Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GHK-CU,RETATRUTIDE
-
Location:
Guangzhou Changkai Trading Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5
-
Total Employees:
Less than 5
-
Year of Establishment:
2026
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
United States
Survodutide cas 2805997-46-8
2 MT Nov 14, 2025
United States
Survodutide
10 MG Oct 7, 2024
United States
Survodutide 10MG
10 MG Nov 17, 2025
Ecuador
Survodutide
10 MG Jun 17, 2026
United States
urvodutide
10 G Aug 10, 2025
Bangladesh
Survodutide
1 KG Jul 3, 2024 Post an enquiry for this product